about
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementin...
Read More
35.29
0.25
(0.71%)
1.1M
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Metsera Inc. is on 03 Sep 2025 for the purpose of Metsera Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Metsera Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..